Abstract
The photosynthetic phosphoenolpyruvate carboxylase isozyme from C4 plants (PEPC-C4) has a complex allosteric regulation, involving positive cooperativity in binding the substrate phosphoenolpyruvate as well as positive and negative allosteric effectors. Besides the proposed R- and T-states, previous kinetic results suggested functionally relevant different R-states of the maize enzyme (ZmPEPC-C4) elicited by PEP or its two kinds of activators, glucose 6-phosphate or glycine. To detect these different R-state conformations, we used as conformational probes the fluorescence of 8-anilino-1-naphthalene sulfonate (ANS), near-UV circular dichroism (CD) spectroscopy, and limited proteolysis by trypsin. Phosphoenolpyruvate and malate binding caused distinct concentration-dependent fluorescence changes of ZmPEPC-C4/ANS, suggesting that they elicited conformational states different from that of the free enzyme, while glucose 6-phosphate or glycine binding did not produce fluorescence changes. Differences were also observed in the near UV CD spectra of the enzyme, free or complexed with its substrate or allosteric effectors. Additionally, differences in the trypsin-digestion fragmentation patterns, as well as in the susceptibility of the free and complexed enzyme to digestion and digestion-provoked loss of activity, provided evidence of several ZmPEPC-C4 conformations in solution elicited by the substrate and the allosteric effectors. Using the already reported ZmPEPC-C4 crystal structures and bioinformatics methods, we predicted that the most probable trypsin-cleavage sites are located in superficial flexible regions, which seems relevant for the protein dynamics underlying the function and allosteric regulation of this enzyme. Together, our findings agree with previous kinetic results, shed light on this enzyme's complex allosteric regulation, and place ZmPEPC-C4 in the growing list of allosteric enzymes possessing an ensemble of closely related R-state conformations.
Keywords: Zea mays L., C4 metabolism, Allosteric regulation, Ligand-induced conformational changes, ANS fluorescence, CD spectroscopy, Trypsin proteolysis
Graphical abstract
Highlights
-
•
PEP or malate binding produce distinct changes in ZmPEPC-C4/ANS fluorescence.
-
•
Different near-UV CD spectra of the free enzyme or of the enzyme complexes were observed.
-
•
PEP or effectors binding produce distinctive ZmPEPC-C4 trypsin-fragmentation patterns.
-
•
Our results support several ligand-induced ZmPEPC-C4 conformational states in solution.
-
•
Predicted trypsin-cleavage sites are at flexible loops, which probably participate in ZmPEPC-C4 function and regulation.
Zea mays L.; C4 metabolism; Allosteric regulation; Ligand-induced conformational changes; ANS fluorescence; CD spectroscopy; Trypsin proteolysis.
1. Introduction
In leaves of C4 plants, two metabolic pathways are involved in the assimilation of the atmospheric CO2: the C4 and the Calvin cycles. In the C4 cycle, the initial CO2 assimilation reaction is the carboxylation of phosphoenolpyruvate (PEP) by the phosphoenolpyruvate carboxylase C4-isozyme (PEPC-C4), which yields oxaloacetate and inorganic phosphate in mesophyll cells of C4 plants [1]. Oxaloacetate is then converted to malate or aspartate, depending on the plant, which are transported to the vascular sheath cells where they produce the CO2 that is finally assimilated into sugars by the Calvin cycle in the chloroplast of these cells.
The importance of the PEPC-C4 isozyme in the photosynthetic CO2 assimilation metabolism of C4 plants is underscored by its complex allosteric regulation —particularly in the case of PEPC-C4 from gramineous C4 plants such as the maize isozyme (ZmPEPC-C4)—, which involves positive cooperativity in the binding of PEP and the positive and negative allosteric effectors [for reviews, see Refs. [2, 3, 4]. At physiological pH, ZmPEPC-C4 is allosterically activated by phospho-sugars, as glucose 6-phosphate (G6P) [5, 6, 7, 8], and the neutral amino acids glycine (Gly) and serine (Ser) [6, 7, 8, 9, 10, 11], whereas is subjected to feedback inhibition by the dicarboxylic acid malate [12, 13]. The two kinds of ZmPEPC-C4 allosteric activators are by no means redundant; they act as separate metabolic signals, both indicating the necessity of a more active C4 cycle under different physiological conditions. Activation of ZmPEPC-C4 by phospho-sugars would increase C4 cycle flux to keep pace with an active Calvin cycle—which leads to the build-up of these phospho-sugars—so that the fluxes of both cycles are coordinated and the C4 cycle does not limit the rate of CO2 assimilation by the Calvin cycle. ZmPEPC-C4 activation by the neutral amino acids glycine and serine—produced during photorespiration—also would increase the CO2 supply to the bundle sheath cells, which in turn would diminish or abolish photorespiration, leading to an increased net CO2 assimilation [14].
The allosteric regulation of ZmPEPC-C4 has been proposed [15, 16] to conform to the symmetry two-state model of Monod, Changeux, and Wyman (MWC model) [17], which postulated that the substrate and allosteric activators shift the preexisting equilibrium between an inactive, or less active, T-state and an active, or more active, R-state, favoring the latter. However, previous kinetic studies [9, 18] suggested that the binding of PEP, G6P, or Gly elicits different R-state conformations of ZmPEPC-C4, which are in equilibrium with the free enzyme, as schematized in Figure 1. The two kinds of activators were found to have a V effect and to be synergic rather than additive, which suggests that (i) the conformation of the enzyme saturated by its substrate PEP is different from that of the enzyme saturated by G6P or Gly, and (ii) this conformation is also different from that existing when the two activators are simultaneously bound to their respective allosteric sites. Moreover, while saturation of ZmPEPC-C4 by G6P is unable to revert the inhibition caused by a physiological concentration of malate, saturation by Gly or Ser produces an enzyme almost as active as that in the absence of the inhibitor [9], again supporting the notion that the two kinds of activators, i.e., phospho-sugars and neutral amino acids, elicit different conformational states.
Figure 1.
Schematic representation of the proposed different conformational states of ZmPEPC-C4 and the equilibria between them. The free enzyme is assumed to predominantly be in the inactive T-state, which changes to a conformationally different malate-bound T-state in the presence of malate, or to different active R-sates in the presence of substrate or allosteric activators. Thus, we propose that the R-state adopts at least three different conformations depending on the binding of PEP, G6P, or Gly. It is likely that different conformations also exist when two or the three of the latter ligands are bound to their respective sites.
The so far reported crystal structures of ZmPEPC-C4 in an active R-state are of a free enzyme (PDB code 1JQO) [19], of the enzyme-Gly complex (PDB code 5VYJ) [20], and of the enzyme-phosphoglycolate-G6P-Gly complex (PDB code 6MGI) [21]. These R-state structures show the correct conformation of the active site and G6P- and Gly-allosteric sites and a disorganized malate-allosteric site, contrary to the reported T-state ZmPEPC-C4 structures, which show disorganized active and activator-allosteric sites and a properly formed malate-allosteric site with bound malate (PDB code 6U2T) or citrate (PDB code 6V3O) [Carrizosa E. I., González-Segura L., and Muñoz-Clares R. A., manuscript in preparation]. As expected, the differences between the R-state and T-state crystal structures are important and multiple, but the differences between the three R-state crystal structures (1JQO, 5VYJ, and 6MGI) are subtle. Thus, although the 1JQO structure has no substrate or allosteric activator bound, it has a similar overall conformation to the 6MGI structure, which has the PEP analog phosphoglycolate bound into the active site and G6P and Gly bound into their respective allosteric sites. The 5VYJ structure, which only has Gly bound in its allosteric site, also has a similar overall conformation, although it shows some differences with the other two R-state structures. Specifically, it differs in the degree of disorder of the loop forming the active site lid and in the conformation of the loop forming the G6P-allosteric site lid. Therefore, it appears that the functionally significant differences in the conformation or dynamics of the enzyme elicited by the substrate or the two kinds of activators, as indicated by the kinetic results, are lost in the crystal structures. The crystallization conditions might favor a single R-state conformation among the several energetically very similar—and therefore easily interconvertible—that probably exist in solution. Because of this, the possible different conformational R-states should be investigated through experiments carried out with the enzyme in solution. The size of this protein—a homotetramer of around 440 kDa—and the probable asymmetry of its subunits derived from high flexibility, as observed in the crystal structures, preclude the use of NMR spectroscopy. NMR using methyl labeling has been used for large proteins, but ZmPEPC-C4 PEPC enzymes have several highly flexible regions in both the R- and T-states according to all reported crystal structures and, consequently, it is expected that they are not fully symmetrical. Indeed, the asymmetric unit in the reported crystal structures was two, four, or even eight. Each small difference between subunits will give different signals in the NMR experiments, and this will greatly complicate the analysis. For these reasons, to detect the conformational changes of ZmPEPC-C4 induced by ligands, in this work we used three other experimental approaches: 1) Extrinsic fluorescence measurements using 8-anilino-1-naphthalene sulfonate (ANS) as a conformational probe; 2) near-UV circular dichroism (CD) spectroscopy, which gives information about changes in the tertiary structure of proteins affecting the surrounding environment of aromatic side chains; and 3) limited proteolysis, since a conformational change in the solution structure of the protein can lead to altered susceptibility to proteolysis. ANS fluorescence changes and limited proteolysis have been successfully used to detect different conformational changes induced by allosteric effectors of the Escherichia coli PEPC enzyme (EcPEPC) [22, 23].
We here report that the substrate PEP changes the fluorescence of the ZmPEPC-C4-ANS complex, while G6P and Gly did not, which suggests that the conformation of the PEP-bound R-state differs from those of the G6P-bound or Gly-bound R-states. We also observed differences in the near-UV CD spectra of the enzyme, free or complexed with its substrate or allosteric effectors. Furthermore, the fragmentation patterns of the enzyme in the absence and presence of PEP, G6P, or Gly were different from each other. Together, our results give strong support to the notion that ZmPEPC-C4 has at least three different R-states, in accordance with previous kinetic results. Besides, based on the prediction of possible trypsin-cleavage sites, we propose the importance of certain flexible regions for the function and allosteric regulation of the enzyme.
2. Materials and methods
2.1. Expression, purification, and assay of recombinant ZmPEPC-C4
The expression and purification of recombinant ZmPEPC-C4 have been previously described [20]. Briefly, the cDNA for ZmPEPC-C4 (ppc-C4, GenBank entry CAD60555, a kind gift from Dr. Katsura Izui) was subcloned into pET32a (+) vector (Novagen) between NcoI/HindIII restriction sites, as described [20]. The resulting plasmid was used for the expression of the full-length, N-terminal double-tagged thioredoxin and His6 ZmPEPC-C4 protein in transformed BL21-CodonPlus (DE3)-RIL E. coli cells (Novagen). Protein purification was achieved by metal-affinity chromatography on a Protino nickel-tris(carboxymethyl)ethylene diamine column (Macherey-Nagel, Düren, Germany). After removal of the double tag by digestion at the thrombin cleavage site with enterokinase (New England Biolabs), the enzyme was further purified using a Mono QHR5 column (GE Healthcare) column. An ÄKTA™ PURE FPLC system (Cytiva) was used in the chromatographic steps. Protein concentration was determined spectrophotometrically by A280 using an extinction coefficient of 111,730 M−1 cm−1 predicted from the amino acid sequence using ExPASy ProtParam [24]. The purity of the recombinant ZmPEPC-C4 was verified by SDS-PAGE after Laemmli [25]. The enzyme was stored at -80 °C in 50 mM HEPES-KOH buffer, pH 7.5, containing 10 mM 2-mercaptoethanol and 10% (v/v) glycerol until use. ZmPEPC-C4 was assayed spectrophotometrically at 30 °C in a coupled enzymatic assay by monitoring NADH oxidation at 340 nm in 100 mM HEPES-KOH pH 7.3 buffer, 5 mM PEP, 10 mM CO3H−, 10 mM Mg2+, 0.25 mM NADH and 4 units of malic dehydrogenase, in the absence or presence of allosteric effectors at the concentrations stated in each experiment.
2.2. Fluorescence measurements
ANS fluorescence was measured at 30 °C with a Shimadzu RF-5000 U spectrofluorimeter in 50 mM HEPES-KOH buffer, pH 7.3, 0.1 mM EDTA, 10 mM 2-mercaptoethanol, and 30 μM ANS. ZmPEPC-C4 concentration was 150 μg/mL (1.37 μM as monomer) and PEP and allosteric effectors concentrations were varied as indicated in the text or the legends of the figures. ANS was excited at 370 nm and emission spectra were recorded between 400-600 nm at 2-min intervals after the addition of 5 μL ligand. The resulting spectra were corrected with those obtained upon the addition of 5 μL buffer. The corrected fluorescence intensities were used to calculate the dissociation constant of ligands by fitting the data to Eq. (1):
| F = {F0 × L0.5h /(L0.5h + [L]h)} + Fmin | (1) |
where F and Fo are the fluorescence intensities at the maximum wavelength of emission observed in the presence and absence of the ligand; respectively; [L] is the concentration of ligand; L0.5 is the ligand concentration giving half of the maximum change in fluorescence, and equals the dissociation constant when the binding of the ligand is hyperbolic; Fmin is the estimated residual fluorescence at saturation of the ligand; and h is the Hill number indicating the degree of cooperativity (h = 1 in hyperbolic binding; h > 1 in positive cooperativity binding). In these calculations, we used total instead of free ligand concentrations since the ligands were in great excess of the enzyme concentration, given their low affinity for the enzyme, and therefore their total concentrations are practically the same as their free concentrations.
2.3. CD spectroscopy
CD signals and dynode voltage were recorded with a Jasco J-715 spectropolarimeter (Jasco Inc., Easton, MD) equipped with a Peltier-type temperature control system (Model PTC-423S) and calibrated with d-10-(+)-camphorsulfonic acid. Near-UV (250–320 nm) spectra were recorded for solutions of 0.35 mg/ml protein concentration placed in quartz cuvettes of 0.5 cm path length. ZmPEPC-C4 was in 10 mM HEPES buffer, pH 7.3, containing 0.5 mM 2-mercaptoethanol. Data were collected at 1 nm intervals, bandwidth of 1.0 nm, and a scan rate of 20 nm/min. Spectra were averaged over 3 scans, and the average spectrum of reference samples without protein was subtracted. The observed ellipticities were converted to molar ellipticities [Θ] on the basis of the molecular mass of the protein (109296.99 Da).
2.4. Limited proteolysis
Digestion of ZmPEPC-C4 with trypsin was conducted at 25 °C in 100 mM HEPES-KOH, pH 7.3, containing 10 mM 2-mercaptoethanol, 1 mM EDTA, and 1 mM CaCl2 at a protease to protein ratio of 1:100 (w/w). To follow the time-course of disappearance and formation of each proteolytic fragment, aliquots of the reaction mixture were withdrawn at the indicated intervals, the reaction stopped with 1 mM phenylmethanesulfonyl fluoride (PMSF; Roche, USA) and immediately subjected to SDS-PAGE on 12 % polyacrylamide minislab gels after Laemmli [25]. Proteins were detected by staining with Coomassie blue R-250. The apparent molecular mass was estimated from SDS-PAGE gels comparing the relative migration with those of standard reference samples of known molecular mass (Bio-Rad, USA). In similar digestion experiments, after stopping the reaction with PMSF, aliquots were assayed for ZmPEPC-C4 activity under standard assay conditions in the absence and presence of saturating concentrations of allosteric effectors.
2.5. Structural analysis
Docking simulations of ANS in the ZmPEPC-C4 crystal structures 5VYJ (R-state with a glycine molecule bound into the neutral amino acids-allosteric site) and 6U2T (T-state with a malate molecule bound into the carboxylic acids-allosteric site) were attempted with DockingServer [26] (https://www.dockingserver.com/web) and Dockthor server [27] (https://dockthor.lncc.br/v2/). The glycine and malate molecules were removed from the corresponding pdb files before the docking simulations. Potential trypsin-cleavage sites were predicted with the PeptideCutter tool in the Expasy (Expert Protein Analysis System) web server [24] (http://expasy.org). The accessible surface area (ASA) was evaluated using the “Accessible Surface Area and Accessibility Calculation for Protein” tool (http://cib.cf.ocha.ac.jp/bitool/ASA/). Protruding atoms were identified using the Concave Finder program (http://cib.cf.ocha.ac.jp/bitool/CONCAVE/), which is based on the CX algorithm [28]. Cx values are the ratio between the external, exposed volume of atoms in a protein and the internal, buried volume (vext/vint). Secondary structure elements of ZmPEPC-C4 were assigned with the program Stride [29] (http://webclu.bio.wzw.tum.de/stride/). The proposed trypsin-cleavage sites were mapped on the crystal structure using PyMOL (http://www.pymol.org/).
3. Results and discussion
3.1. ANS fluorescence measurements
The binding of the substrate PEP or the allosteric effectors G6P, Gly, or malate did not induce any measurable change in the tryptophan fluorescence of ZmPEPC-C4; thus intrinsic fluorescence could not be exploited to investigate ligand-induced conformational changes in solution. Therefore, to characterize the dynamic properties of ZmPEPC-C4 upon ligand binding, we used the fluorescence probe ANS, which has a low fluorescence yield in aqueous solution but exhibits enhanced fluorescence when bound to hydrophobic sites on proteins [30].
In the absence of ligands, ANS binds to ZmPEPC-C4 and produces an emission spectrum with a maximum at 476 nm (Figure 2 A, B). The allosteric activators G6P and Gly did not significantly affect the maximum ZmPEPC-C4/ANS-fluorescence even at high concentrations (data not shown). Therefore, ANS is not adequate to detect the conformational changes elicited by these two kinds of allosteric activators. On the contrary, the substrate PEP and the allosteric inhibitor malate decreased the maximum ZmPEPC-C4/ANS-fluorescence to a different extent (Figure 3 A, B). The fluorescence signal changes in response to the binding of PEP or malate are a function of ligand concentration (Figure 3 C, D). The corresponding fits of the fluorescence data to Eq. (1) yield the binding parameters given in the table included in Figure 3. The estimated L0.5 value and the degree of binding cooperativity for PEP agree reasonably well with those previously found in experiments where the protection of the enzyme activity afforded by PEP against chemical modification by pyridoxal phosphate was measured [31]. Thus, the estimated L0.5 and h values for PEP in the referred study were 5.33 ± 0.32 mM and 2.43 ± 0.33, respectively, while the values estimated by ANS fluorescence in the present study are 5.42 ± 0.62 mM and 3.2 ± 0.9, respectively. Similarly, the estimated binding parameters for malate are close to the reported inhibition parameters found for malate in initial velocity experiments: I50 0.43 ± 0.04 mM and h 1 [32] versus L0.5 0.36 ± 0.07 mM and h 0.9 ± 0.2 in the present study.
Figure 2.
ANS-dependent fluorescence response in ZmPEPC-C4. (A) Emission spectra of ZmPEPC-C4/ANS solutions in the presence of increasing concentrations of ANS. The protein concentration was 1.37 μM as monomer. ANS was excited at 370 nm. Spectra were corrected with those of the buffer. (B) ANS-concentration dependence of the fluorescence signal at 476 nm. The dissociation constant (Kd) of the ANS-ZmPEPC-C4 complex was calculated by fitting the data to y = ymax∗[ANS]/(Kd + [ANS]), where y are the fluorescence data. The estimated Kd value was 14.5 ± 1.5 μM.
Figure 3.
Extrinsic fluorescence studies. Emission spectra of ZmPEPC-C4/ANS solutions in the presence of increasing concentrations of PEP (A), or malate (B). a.u., arbitrary units. (C and D) Ligand-concentration-dependent fluorescence changes. The lines are drawn from the best fit of the changes in fluorescence intensity at the maximum emission wavelength (476 nm) to Eq. (1), which gives the binding parameters shown in the table inserted in this figure. Fluorescence changes are expressed as a percentage of the fluorescence measured in the absence of ligand (F0).
The differences in the response of the enzyme upon binding of the two ligands—highly cooperative in the case of PEP and non-cooperative in the case of malate—suggest that the PEP-induced conformational state is different from the malate-induced conformational state, although both appear to be either more compact or with less hydrophobic patches exposed. Thus, the ANS-fluorescence data suggest that binding of PEP or malate induces two different allosteric transitions to conformational states different from that of the free enzyme: the one induced by the substrate PEP, which cooperatively shifts the equilibrium between the T0 state present in the absence of ligands towards the PEP-bound R state, and the one induced by malate, which non-cooperatively induces or stabilizes a different T state, the malate-bound T state, as depicted in Figure 1. This finding is consistent with previously reported ZmPEPC-C4 kinetic data, which showed cooperativity in PEP binding and no-cooperativity in malate binding [9, 32]. Also, the finding that the allosteric transition induced by either G6P or Gly did not affect ANS binding suggests differences between the PEP-bound R state and the G6P-bound or Gly-bound R states, but the possible differences between the two latter R states could not be studied using this technique.
We can not rule out the possibility that ANS binds to the active site or the malate-allosteric site and therefore that PEP and malate displace the fluorophore instead of inhibiting its binding through a conformational change. Nonetheless, we think that the probability of doing so is low given (i) the highly polar nature of the PEP- and malate-binding sites, although they could bind the sulfonic group of ANS; (ii) the good agreement of the values of the binding parameters with those determined by different experimental methods; and (iii) our failure to obtain by docking simulations the ANS molecule inside the active or malate-binding sites of the ZmPEPC-C4 5VYJ (glycine-bound R state) or 6U2T (malate-bound T state) crystal structures (results not shown). Indeed, the best poses obtained showed that ANS binds at the protein surface, off of the active or allosteric sites; but again we are aware that dockings results are not conclusive proofs. But even if isosteric competitive binding caused the decreases in fluorescence of the ZmPEPC-C4-ANS complex, our data represent a valuable contribution to the knowledge of the mode of binding of PEP and malate and the allosteric transitions elicited by them. But because the fluorescence results did not inform about possible differences between the conformational states triggered or stabilized by the two kinds of allosteric effectors of this enzyme, we tried different experimental approaches to detect the existence of the distinct conformational states suggested by the kinetic studies.
3.2. CD spectra
The CD spectra in the near-UV region of free or ligand-bound ZmPEPC-C4 are shown in Figure 4A. To the best of our knowledge, this is the first report of CD spectroscopy performed in a PEPC enzyme. The considerable number of aromatic residues in ZmPEPC-C4 (38 Phe, 27 Tyr, and 13 Trp per subunit) precludes a detailed analysis of the spectra. Nevertheless, the differences between these spectra (depicted in Figure 4B as the difference spectra obtained subtracting the CD spectrum of the free enzyme from the CD spectrum of each enzyme complex) suggest changes in the local environment of some of these residues and, therefore, different enzyme conformations. When compared with the free enzyme, the E-malate complex spectrum showed the most remarkable changes, but differences were also observed in the CD spectra of the E-PEP, E-G6P, and E-Gly complexes, not only relative to the spectrum of the free enzyme but also between them. These results confirm the change to a T-state bound conformation elicited by the inhibitor malate and support that several distinct R-state conformations are elicited by the binding of the substrate PEP or the two kinds of allosteric activators.
Figure 4.
Circular dichroism studies. (A) Near-UV CD Spectra of ZmPEPC-C4 in the absence or presence of the substrate PEP or allosteric effectors. (B) Near-UV CD difference spectra were obtained subtracting the CD spectrum of the free enzyme from the CD spectrum of each enzyme complex. Ligands concentrations were: 10 mM PEP, 15 mM G6P, 100 mM Gly, and 10 mM malate.
3.3. Fragmentation patterns obtained by limited proteolysis
To further assess the possible existence of different active R-state conformations characteristic of the different complexes of ZmPEPC-C4 with its substrate or with any of its two kinds of allosteric activators, we conducted limited proteolysis experiments by subjecting the protein loaded with PEP, G6P, or Gly to trypsin digestion and comparing the fragmentation patterns and the rates of fragment formation and degradation with those of the free, non-ligand-bound enzyme (Figure 5A). Similar experiments were performed with the enzyme-malate complex to test whether the inactive T-sate can also be detected using this experimental approach.
Figure 5.
Limited proteolysis studies. ZmPEPC-C4 was incubated with trypsin in the absence or presence of the substrate PEP or allosteric effectors and samples were withdrawn at the indicated times. The fragmentation patterns were visualized by SDS-PAGE (A), or the residual enzymatic activity was measured either in the absence of any effector (B) or in the presence of 10 mM malate (C). Ligands concentrations were: 10 mM PEP, 15 mM G6P, 100 mM Gly, and 10 mM malate. In panel B are given the average activities values measured using the standard assay at each time of incubation, expressed as the percentage of the average activity value measured at time zero, which as U/mg prot was: free-E = 0.633 ± 0.007; E-PEP = 0.975 ± 0.020; E-G6P = 1.251 ± 0.028; E-Gly = 1.036 ± 0.071; E-malate = 0.205 ± 0.014. In panel C are given the values of the percentage of inhibition by 10 mM malate measured at each time of incubation. The percentage of inhibition values at time zero were: free-E = 84.5 ± 0.2; E-PEP = 60.7 ± 4.2; E-G6P = 63.7 ± 9.5; E-Gly = 39.5 ± 1.4; E-malate: 47.8 ± 3.9. Some malate inhibition values at the longer times are not included in panel C because the activity in the absence of malate was so low that the determination of the degree of inhibition by malate was not reliable. The differences in the values at time zero between the free enzyme and the enzyme complexes are due to the presence of the ligands in the samples of the complexes. The full, uncropped versions of the SDS-PAGE gels shown in panel A are provided in the Supplementary Material (Fig. S1).
Trypsin quickly cleaved free ZmPEPC-C4, while the ligand-bound enzyme forms were more resistant to digestion, particularly the complex enzyme-PEP. In the case of the free enzyme, after only 0.5 min incubation, a significant proportion of the intact protein was digested, producing a fragment of around 90 kDa, indicating a cleavage site very susceptible to trypsin proteolysis in the free enzyme. A second smaller fragment was also quickly formed, and after 60-min incubation, the protein was totally digested. The enzyme complexed with PEP was considerably more resistant to digestion, and the two major fragments formed, one of them in the first minutes of the incubation, accounted for almost all the initial amount of protein even after 120 min of incubation. In the enzyme-G6P complex, the intact protein was more quickly digested than in the enzyme-PEP complex, but not as quickly as in the free enzyme. After 15 min incubation, two major fragments were formed, but different from those formed in the complex enzyme-PEP, they were quite susceptible to further digestion. The digestion pattern of the enzyme-Gly complex is different from those of the enzyme-PEP and enzyme-G6P complexes, even though it would be expected the same active R-state in these three complexes if the MWC two-state allosteric model applied for ZmPEPC-C4. After 15 min of incubation of the enzyme-Gly complex, three major fragments were formed. The amount of the fragment with the lower molecular mass increased with the digestion time and was very resistant to further proteolysis. It accounted for most of the undigested protein after 120-min incubation, suggesting that it has not accessible trypsin-cleavage sites or that its cleavage was considerably slow. Finally, the intact protein in the complex enzyme-malate was initially almost as resistant to trypsin as in the enzyme-PEP complex, but the major fragment formed is not as trypsin-resistant as the one formed when PEP is bound, so that a considerable number of smaller fragments were formed in the following minutes of incubation. This finding suggests that this major fragment is partially unstructured and exposes several new trypsin cleavage sites. After 120 min of digestion, the protein was almost completely digested.
Interestingly, the differences in the fragmentation patterns between free ZmPEPC-C4 and its complexes with the substrate or allosteric effectors, as well as those between the four enzyme-complexes, were observed not only at the first minutes of incubation with trypsin but also at much longer times. Although we did not identify the different tryptic-cleavage sites in the studied enzyme complexes, the evolution of the fragmentation patterns during an extended time of incubation (up to 120 min) was also informative about the conformational states of ZmPEPC-C4 elicited by its ligands. Our findings indicate that the different high-mass peptides formed at short times have different susceptibility to trypsin digestion and therefore seem not to have the same conformation despite apparently having similar masses.
In summary, the differences in the digestion patterns of the free ZmPEPC-C4 enzyme and its different complexes indicate that some cleavage sites are more or less available for tryptic cleavage depending on the ligand-bound, thus revealing different conformational states in solution of this enzyme, as suggested by previous kinetic results. Thus, our results show that the trypsin digestion method is very sensitive to detecting different ZmPEPC-C4 conformations in solution. It allowed the detection of not only those conformations expected to be very different, as the T-state elicited by the inhibitor malate and the R-state elicited by the substrate, but also those conformations that probably are slightly different, as the R-states elicited by the substrate or any of the two kinds of allosteric activators. Therefore, tryptic digestion might be a powerful and straightforward method for exploring the conformational space available in PEPC enzymes in particular and in enzymes subjected to allosteric regulation in general.
3.4. Effects of incubation with trypsin in the activity and sensitivity to allosteric effectors
To further substantiate the above-described results, we measured the residual activity and sensitivity to allosteric effectors of the free enzyme and the different enzyme complexes during their incubation with trypsin for 60 min. The loss of activity, expressed as the percentage of the activities of the free enzyme and different enzyme complexes measured at time zero of incubation with trypsin, are shown in Figure 5B. The changes in sensitivity to malate, expressed as the percentage of the enzyme inhibition by 10 mM malate measured at time zero of incubation, are shown in Figure 5C.
Consistent with the digestion patterns, important differences were found between the free and ligand-bound enzymes. The free enzyme rapidly lost activity—which agrees with the observed rapid digestion of the protein—while the enzyme in complex with PEP retained an important percentage of its initial activity, even after 60 min-incubation (Figure 5B). The latter finding suggests that at least one of the two fragments formed in the trypsin digestion of the enzyme-PEP complex, presumably the one with the higher molecular mass, has an intact active site. To find out whether these fragments conserved the quaternary tetrameric arrangement of the intact enzyme we subjected a sample of the enzyme-PEP complex to trypsin digestion for 60 min and then to size exclusion chromatography. But we could not obtain an elution profile because the protein was retained in the pre-column filter, suggesting that these fragments are highly hydrophobic and aggregated at concentrations above the low ones used in the activity assays. The enzyme-G6P and enzyme-Gly complexes were also more stable against trypsin-provoked activity losses than the free enzyme (Figure 5B). Gly afforded higher protection than G6P, probably because the amount of the intact protein remaining during the incubation is higher in the enzyme-Gly complex than in the enzyme-G6P complex. Finally, the stabilizing effects of malate were intermediate between those of G6P and Gly, a result also consistent with the higher stabilization afforded by this inhibitor against trypsin digestion of the intact protein.
In all enzyme complexes, the enzyme that remained active through the incubation appears to be equally sensitive to activation by G6P and Gly as at zero time (data not shown), but in the free enzyme and the PEP- and G6P- complexes a rapid partial loss of sensitivity to malate was observed within the first 5 min of incubation (Figure 5C). This reduced malate inhibition might result from the removal of an N-terminal fragment, as previously reported [33]. On the contrary, the sensitivity for malate of the enzyme-malate complex rapidly increased upon incubation with trypsin (Figure 5C) for a so far unknown reason. This interesting observation deserves further investigation since it could shed light on the structural bases of the mechanism of inhibition of PEPC enzymes by carboxylic acids.
3.5. Possible sites of trypsin cleavage
To further our understanding of the fragmentation patterns obtained, we next investigated the possible trypsin-cleavage sites in the ZmPEPC-C4 protein using the bioinformatics methods described in the Materials and Methods section.
It is known that trypsin cleaves proteins on the C-terminal side of lysine or arginine [34], and a total of 119 potential cleavage sites were predicted in ZmPEPC-C4 by the PeptideCutter tool. To narrow the selection of the probable cleavage-sites, and considering that the more accessible and protruding protein regions are the more likely to interact with trypsin, we carried out an analysis of the ASA and cx values of every protein residue using the available ZmPEPC-C4 crystal structures (Figure 6 A, B; Fig. S2 A, B; Fig. S3 A, B; Table S1). As possible cleavage sites, we selected lysine and arginine residues that: (i) show the high ASA and cx values, (ii) are at flexible loops that could allow the binding at the active site of the protease [35, 36, 37], and (iii) do not have aspartate or glutamate at one or two positions before lysine or arginine, because it is known that they greatly slow the rate of hydrolysis [38]. We did not consider the “Keil rule”, which proposes that cleavage does not occur if proline is after arginine or lysine [39], because this rule has been questioned given the abundance of cuts before proline in MS/MS data sets [40]. Applying these criteria, after a visual examination of the ZmPEPC-C4 amino acid sequence and the topology of its crystal structures (Figs. 6C, S1C, and S2C), combined with the results of the ASA and cx analysis, we propose that the most likely cleavage sites are Lys125, Lys203, Lys353/Lys356, Lys497/Arg498, Arg556, Lys762/Arg763, Lys807, Lys878, Lys918, and Lys940. In addition, we propose that Lys5, Arg21, Lys27, and Lys127/Lys128 also are probable trypsin-cleavage sites since they are located in flexible regions—they did not show electronic density in any of the three reported R-state ZmPEPC-C4 crystal structures—, and are not preceded by an acidic residue (Figs. 6C, S1C, and S2C, and Table S1). It seems reasonable to assume that, after cuts in the N-terminal segment, the peptide observed results from the cut at Lys27. Indeed, what we have called the intact enzyme in the experiments with the free enzyme and with the enzyme-PEP and enzyme-G6P complexes may be the one resulting from a cut at Lys27, which would be consistent with their rapid loss of sensitivity to malate, as mentioned. Nevertheless, in the enzyme-Gly complex, the complete protein could be the first band observed in the SDS-PAGE gels since malate sensitivity is retained. Cuts at Lys934 also are very likely. This is a very flexible residue, which is observed only in subunit A of the 6MGI structure where it is highly exposed.
Figure 6.
Prediction of trypsin-cleavage sites in ZmPEPC-C45VYJ crystal structure. Of the three reported ZmPEPC-C4 R-state structures, this is the one exhibiting more residues with associated electronic density. Shown are the results obtained using chain A. The residues of the trypsin-cleavage sites, predicted according to the criteria given in the text, are shown, and their ASA (A) and cx (B) values are indicated by red arrows. (C) Protein sequence and topology showing the position of the predicted cleavage sites. In cyan and magenta are marked the residues where the most and less likely cuts, respectively, could occur. Active site and allosteric sites residues are marked with colored circles to compare their positions in the protein sequence to those of the predicted trypsin-cleavage sites.
It is clear that in the protein sequence, the predicted trypsin-cleavage sites are not close to either active or allosteric sites residues, as shown in Figure 6C. Thus, to further explore the protein regions where the predicted cuts may occur, we mapped these cleavage sites on the three-dimensional structure of ZmPEPC-C4 (Figure 7A) and found that neither are they close to the active site or allosteric sites (Figure 7 B, C). Therefore, it seems that the differences in their susceptibility to trypsin cleavage do not arise from protection by a particular ligand bound to the enzyme.
Figure 7.
Mapping of the predicted trypsin-cleavage sites on the ZmPEPC-C4 5VYJ crystal structure. Sausage B-factors representation of the tetramer showing static disorder in some loops. The structure is colored according to monomer in (A) and according to B-factors values in (B) and (C). Residues predicted as the most likely trypsin-cleavage sites are shown in panels (B) and (C) mapped in chain A. The position of the first residue observed in the N-terminal region (Glu36) and well as the positions of the active and allosteric sites are indicated in panel (B).
By visual inspection of the structure, it can be seen that cuts at Lys497/Arg498 and Arg556 cannot occur because they are located at the dimer-dimer interface of the tetramer (note that our predictions were based on these residues being highly exposed in the monomer used for the accessibility estimations) and therefore not accessible to the protease in the native enzyme. Similarly, cuts at Lys353/Lys356 are not probable since these residues are at the monomer interface in dimeric units. This deduction is consistent with the absence of digestion fragments of the corresponding size at the shorter incubation times. The other predicted cleavage sites are exposed in the tetramer and are located in very flexible regions or loops, as indicated by either their lack of electronic density or high Cα-B factor values compared with the average value (Figure 7 B, C). In particular, these sites are at 1) the N-terminal region—not observed in the three reported ZmPEPC-C4 R-state crystal structures—, 2) at the Ser125- Ile144 loop—part of which is not observed in any of these R-state structures—, 3) at the Asn755-Arg773 loop that forms the active site lid—which is observed in the 5VYJ structure but is disordered at Lys762/Arg763/Arg764 in the 1JQO and 6MGI structures—, and 4) at the Pro915-Glu932 loop—which was completely observed only in subunit A of the 6MGI structure. In subunit B of the asymmetric unit of 6MGI and every subunit of 1JQO and 5VYJ, the short segment of Pro915-Glu932 loop not observed includes Lys934 (Figs. 6C, S1C, and S2C). A combination of cuts at the predicted trypsin-susceptible sites in these loops, plus the ones located in the flexible regions without electronic density in the crystal structures, could account for the observed digestion fragments in the different enzyme complexes, as shown in Table 1. Interestingly, it was reported that the incubation of the free EcPEPC enzyme with trypsin produced a cut at Arg703 [41], which is the arginine residue equivalent to Arg763 of ZmPEPC-C4 predicted by us as a highly possible cleavage site in the maize enzyme.
Table 1.
Molecular masses of possible peptides obtained after tryptic digestion of ZmPEPC-C4. Possible trypsin-cleavage sites were predicted according to the criteria stated in the text. Molecular masses were estimated using the ProtParam tool (https://web.expasy.org/protparam/). Only the peptides of high molecular mass (Mr) are included in this analysis. The intact recombinant enzyme used has 971 residues and a Mr value of 109,416 Da.
| Peptide | Number of residues | Mr (Da) |
|---|---|---|
| K27-K940 | 912 | 103,267 |
| K27-K934 | 907 | 102,857 |
| K27-K918 | 891 | 101,075 |
| K27-R878 | 851 | 96,385 |
| K27-R807 | 780 | 88,116 |
| K27-R764 | 737 | 83,306 |
| K125-K940 | 814 | 92,447 |
| K125-K934 | 808 | 91,882 |
| K125-K918 | 792 | 90,100 |
| K125-K878 | 753 | 85,565 |
| K125-K807 | 682 | 77,297 |
| K125-R764 | 639 | 72,487 |
| K203-K940 | 736 | 83,850 |
| K203-K918 | 714 | 81,502 |
| K203-K878 | 675 | 76,968 |
| K203-K807 | 604 | 68,699 |
| K203-R764 | 561 | 63,889 |
Our findings of distinct trypsin-fragmentation patterns of the free enzyme and the different enzyme complexes suggest that the conformation of the above-mentioned flexible regions at the protein surface —which, as said before, are not directly involved in binding of the substrate PEP or of the allosteric effectors—are very sensitive to the binding of the different ligands. Also, they might play essential roles in the catalysis or allosteric regulation of the ZmPEPC-C4 isozyme and, presumably, of plant PEPC enzymes in general. The N-terminal region before α1 and the loops mentioned above may also be necessary for bacterial PEPC enzymes. However, some of them are shorter than those present in the plant enzymes, as can be seen in the reported EcPEPC crystal structures (PDB codes 1FIY, 1QB4, and 1JQN) [41, 42, 43]—an enzyme in which multiple conformational states have also been detected in solution [22, 23, 44, 45, 46]. The whole loop of the active site lid—to which Lys762/Arg763/arg764 (ZmPEPC-C4 numbering) belong—is also present in the bacterial enzymes, and its amino acid sequence is highly conserved in both bacterial and plant PEPCs, supporting a critical role in the function of these enzymes.
Different conformations have been well documented in several allosteric proteins, particularly in hemoglobin, where closely related conformational states with different tertiary structures have been proposed to explain the binding properties of this protein [47, 48, 49, 50] and references therein]. Other allosteric enzymes may also present different R-states, as is the glucosamine-6-phosphate deaminase from E. coli, whose different R-states were demonstrated by fluorescence spectroscopy [51]. Regarding PEPC enzymes, the great conformational flexibility that gives rise to the multiplicity of ligand-induced, or ligand-stabilized, conformational states appears to be a general feature of PEPC enzymes and not only of the EcPEPC previously reported.
4. Conclusions
The results from the combined experimental and bioinformatic methods used in this work support the existence of multiple conformations of ZmPEPC-C4 in solution and point out the importance of certain flexible regions at the protein surface for the PEPC enzymes dynamics underlying their function and allosteric regulation. Together, our results contribute to understanding the complex allosteric regulation of PEPC enzymes in general and of the plant ZmPEPC-C4 isozyme in particular, which is an important biotechnological target in the efforts to increase crops yields.
Declarations
Author contribution statement
Fátima Barreda-Huerta: Performed the experiments; Analyzed and interpreted the data.
Ismael Bustos-Jaimes: Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data.
Carlos Mújica-Jiménez: Performed the experiments.
Rosario A. Muñoz-Clares: Conceived and designed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.
Funding statement
Rosario A. Muñoz-Clares was supported by UNAM, grant PAPIIT IN216911. Fátima Barreda-Huerta was supported by a CONACYT scholarship.
Data availability statement
Data will be made available on request.
Declaration of interests statement
The authors declare no conflict of interest.
Additional information
No additional information is available for this paper.
Acknowledgements
We acknowledge the participation of the deceased Dr. G. Mendoza, Faculty of Medicine, UNAM, in preliminary mass spectrometry experiments.
Appendix A. Supplementary data
The following is the supplementary data related to this article:
References
- 1.Hatch M.D. C4 photosynthesis: an unlikely process full of surprises. Plant Cell Physiol. 1992;33:333–342. [Google Scholar]
- 2.Andreo C.S., González D.H., Iglesias A.A. Higher plant phosphoenolpyruvate carboxylase: structure and regulation. FEBS Lett. 1987;213:1–8. [Google Scholar]
- 3.Chollet R., Vidal J., O´Leary M.H. Phosphoenolpyruvate carboxylase: a ubiquitous, highly regulated enzyme in plants. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1996;47:273–298. doi: 10.1146/annurev.arplant.47.1.273. [DOI] [PubMed] [Google Scholar]
- 4.Izui K., Matsumura H., Furumoto T., Kai Y. Phosphoenolpyruvate carboxylase: a new era of structural biology. Annu. Rev. Plant Biol. 2004;55:69–84. doi: 10.1146/annurev.arplant.55.031903.141619. [DOI] [PubMed] [Google Scholar]
- 5.Wong K.F., Davies D.D. Regulation of phosphoenolpyruvate carboxylase of Zea mays by metabolites. Biochem. J. 1973;131:451–458. doi: 10.1042/bj1310451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Doncaster H.D., Leegood R.C. Regulation of phosphoenolpyruvate carboxylase activity in maize leaves. Plant Physiol. 1987;84:82–87. doi: 10.1104/pp.84.1.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bandarian V., Poehner W.J., Grover S.D. Metabolite activation of crassulacean acid metabolism and C4 phosphoenolpyruvate carboxylase. Plant Physiol. 1992;100:1411–1416. doi: 10.1104/pp.100.3.1411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Tovar-Méndez A., Rodríguez-Sotres R., López-Valentín D.M., Muñoz-Clares R.A. Re-examination of the roles of PEP and Mg2+ in the reaction catalysed by the phosphorylated and non-phosphorylated forms of phosphoenolpyruvate carboxylase from leaves of Zea mays: effects of the activators glucose 6-phosphate and glycine. Biochem. J. 1998;332:633–642. doi: 10.1042/bj3320633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tovar-Méndez A., Mújica-Jiménez C., Muñoz-Clares R.A. Physiological implications of the kinetics of maize leaf phosphoenolpyruvate carboxylase. Plant Physiol. 2000;123:149–160. doi: 10.1104/pp.123.1.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Nishikido T., Takanashi H. Glycine activation of PEP carboxylase from monocotyledonous C4 plants. Biochem. Biophys. Res. Commun. 1973;53:126–133. doi: 10.1016/0006-291x(73)91410-1. [DOI] [PubMed] [Google Scholar]
- 11.Gillinta J., Grover S.D. Kinetic interactions of glycine with substrates and effectors of phosphoenolpyruvate carboxylase from maize leaves. Photosynth. Res. 1995;45:121–126. doi: 10.1007/BF00032583. [DOI] [PubMed] [Google Scholar]
- 12.Huber S.C., Edwards G.E. Inhibition of phosphoenolpyruvate carboxylase from C4 plants by malate and aspartate. Can. J. Bot. 1975;53:1925–1933. [Google Scholar]
- 13.González D.H., Iglesias A.A., Andreo C.S. On the regulation of phosphoenolpyruvate carboxylase activity from maize leaves by L-malate. Effect of pH. J. Plant Physiol. 1984;116:425–434. doi: 10.1016/S0176-1617(84)80134-0. [DOI] [PubMed] [Google Scholar]
- 14.Leegood R.C. The intercellular compartmentation of metabolites in leaves of Zea mays L. Planta. 1985;164:163–170. doi: 10.1007/BF00396078. [DOI] [PubMed] [Google Scholar]
- 15.Frank J., Vater J., Holzwarth J.F. Kinetics and equilibrium binding of phosphoenolpyruvate to phosphoenolpyruvate carboxylase from Zea mays. Phys. Chem. Chem. Phys. 1999;1:455–461. doi: 10.1016/s0301-4622(01)00185-5. [DOI] [PubMed] [Google Scholar]
- 16.Frank J., Clarke R.J., Vater J., Holzwarth J.F. Influence of allosteric effectors on the kinetics and equilibrium binding of phosphoenolpyruvate (PEP) to phosphoenolpyruvate carboxylase (PEPC) from Zea mays. Biophys. Chem. 2001;30:53–64. doi: 10.1016/s0301-4622(01)00185-5. [DOI] [PubMed] [Google Scholar]
- 17.Monod J., Wyman J., Changeux J. On the nature of allosteric transitions. A plausible model. J. Mol. Biol. 1965;12:88–118. doi: 10.1016/s0022-2836(65)80285-6. [DOI] [PubMed] [Google Scholar]
- 18.Mújica-Jiménez C., Castellanos-Martínez A., Muñoz-Clares R.A. Studies of the allosteric properties of maize leaf phosphoenolpyruvate carboxylase with the phosphoenolpyruvate analog phosphomycin as activator. Biochim. Biophys. Acta. 1998;1386:132–144. doi: 10.1016/s0167-4838(98)00093-4. [DOI] [PubMed] [Google Scholar]
- 19.Matsumura H., Xie Y., Shirakata S., Inoue T., Yoshinaga T., Ueno Y., Izui K., Kai Y. Crystal structures of C4 form maize and quaternary complex of E. coli phosphoenolpyruvate carboxylases. Structure. 2002;10:1721–1730. doi: 10.1016/s0969-2126(02)00913-9. [DOI] [PubMed] [Google Scholar]
- 20.González-Segura L., Mújica-Jiménez C., Juárez-Díaz J.A., Güémez-Toro R., Martínez-Castilla L.P., Muñoz-Clares R.A. Identification of the allosteric site for neutral amino acids in the maize C4 isozyme of phosphoenolpyruvate carboxylase: the critical role of Ser-100. J. Biol. Chem. 2018;293:9445–9957. doi: 10.1074/jbc.RA118.002884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Muñoz-Clares R.A., González-Segura L., Andrés Juárez-Díaz J., Mújica-Jiménez C. Structural and biochemical evidence of the glucose 6-phosphate-allosteric site of maize C4-phosphoenolpyruvate carboxylase: its importance in the overall enzyme kinetics. Biochem. J. 2020;477:2095–2114. doi: 10.1042/BCJ20200304. [DOI] [PubMed] [Google Scholar]
- 22.Yoshinaga T. Phosphoenolpyruvate carboxylase of Escherichia coli: studies on multiple conformational states elicited by allosteric effectors with fluorescence probe, 1-anilinonaphthalene-8-sulfonate. Biochim. Biophys. Acta. 1976;452:566–579. doi: 10.1016/0005-2744(76)90208-4. [DOI] [PubMed] [Google Scholar]
- 23.Kameshita I., Izui K., Katsuki H. Phosphoenolpyruvate carboxylase of Escherichia coli: effect of proteolytic modification on the catalytic and regulatory properties. J. Biochem. 1979;86:1–10. [PubMed] [Google Scholar]
- 24.Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., Bairoch ExPASy A. The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31:3784–3788. doi: 10.1093/nar/gkg563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Laemli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- 26.Bikadi Z., Hazai E. Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J. Cheminf. 2009;15:1–16. doi: 10.1186/1758-2946-1-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.De Magalhães C.S., Almeida D.M., Barbosa H.J.C., Dardenne L.E. A dynamic niching genetic algorithm strategy for docking of highly flexible ligands. Inf. Sci. 2014;289:206–224. [Google Scholar]
- 28.Pintar A., Carugo O., Pongor S. CX, an algorithm that identifies protruding atoms in proteins. Bioinformatics. 2002;18(7):980–984. doi: 10.1093/bioinformatics/18.7.980. [DOI] [PubMed] [Google Scholar]
- 29.Frishman D., Argos P. Knowledge-based protein secondary structure assignment. Proteins. 1995;23:566–579. doi: 10.1002/prot.340230412. [DOI] [PubMed] [Google Scholar]
- 30.Dodd G.H., Radda G.K. 1-Anilinonaphthalene-8-sulphonate, a fluorescent conformational probe for glutamate dehydrogenase. Biochem. J. 1969;114:407–417. doi: 10.1042/bj1140407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Tovar-Méndez A., Yampara-Iquise H., Mújica-Jiménez C., Muñoz-Clares R.A. In: Photosynthesis: from Light to Biosphere. Mathis P., editor. Vol. 5. Kluwer; Dordrecht: 1995. Binding of ligands to the glucose-6-phosphate allosteric site in maize-leaf phopshoenolpyruvate carboxylase; pp. 155–158. [Google Scholar]
- 32.Güemez-Toro R., Mújica-Jiménez C., Muñoz-Clares R.A. Allosteric regulation of the photosynthetic C4 isoenzyme of phosphoenolpyruvate carboxylase: a comparative study between enzymes from monocot and eudicots. J. Mex. Chem. Soc. 2012;56:58–66. [Google Scholar]
- 33.Wang Y.H., Duff M.G., Lepiniec L., Crétin C., Sarath G., Condon S.A., Vidal J., Gadal P., Chollet R. Site-directed mutagenesis of the phosphorylatable serine (Ser8) in C4 phosphoenolpyruvate carboxylase from sorghum. The effect of negative charge at position 8. J. Biol. Chem. 1992;267:16759–16762. [PubMed] [Google Scholar]
- 34.Olsen J.V., Ong S.E., Mann M. Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol. Cell. Proteomics. 2004;3:608–614. doi: 10.1074/mcp.T400003-MCP200. [DOI] [PubMed] [Google Scholar]
- 35.Abramowitz N., Schechter I., Berger A. On the size of the active site in proteases. II. Carboxypeptidase-A. Biochem. Biophys. Res. Commun. 1967;29:862–867. doi: 10.1016/0006-291x(67)90299-9. [DOI] [PubMed] [Google Scholar]
- 36.Hubbard S.J., Argos P. Cavities and packing at protein interfaces. Protein Sci. 1994;3:2194–2206. doi: 10.1002/pro.5560031205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hubbard S.J., Beynon R.J., Thornton J.M. Assessment of conformational parameters as predictors of limited proteolytic sites in native protein structures. Protein Eng. Des. Sel. 1998;11:349–359. doi: 10.1093/protein/11.5.349. [DOI] [PubMed] [Google Scholar]
- 38.Šlechtová T., Gilar M., Kalíková K., Tesařová E. Insight into trypsin miscleavage: comparison of kinetic constants of problematic peptide sequences. Anal. Chem. 2015;87:7636–7764. doi: 10.1021/acs.analchem.5b00866. [DOI] [PubMed] [Google Scholar]
- 39.Keil B. Specificity of Proteolysis. Springer; Berlin, Heidelberg: 1992. Essential substrate residues for action of endopeptidases. [Google Scholar]
- 40.Rodriguez J., Gupta N., Smith R.D., Pevzner P.A. Does trypsin cut before proline? J. Proteome Res. 2008;7:300–305. doi: 10.1021/pr0705035. [DOI] [PubMed] [Google Scholar]
- 41.Kai Y., Matsumara H., Inoue T., Terada K., Nagara Y., Yoshinaga T., Kihara A., Tsumura K., Izui K. Three-dimensional structure of phosphoenolpyruvate carboxylase: a proposed mechanism for allosteric inhibition. Proc. Natl. Acad. Sci. Unit. States Am. 1999;96:823–828. doi: 10.1073/pnas.96.3.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Matsumura H., Terada M., Shirakata S., Inoue T., Yoshinaga T., Izui K., Kai Y. Plausible phosphoenolpyruvate binding site revealed by 2.6 Å structure of Mn2+-bound phosphoenolpyruvate carboxylase from Escherichia coli. FEBS Lett. 1999;458:93–96. doi: 10.1016/s0014-5793(99)01103-5. [DOI] [PubMed] [Google Scholar]
- 43.Matsumura H., Xie Y., Shirakata S., Inoue T., Yoshinaga T., Ueno Y., Izui Y.K., Kai Y. Crystal structures of C4 from maize and quaternary complex of E. coli phosphoenolpyruvate carboxylases. Structure. 2002;10:1721–1730. doi: 10.1016/s0969-2126(02)00913-9. [DOI] [PubMed] [Google Scholar]
- 44.Izui K. Kinetic studies on the allosteric nature of phosphoenolpyruvate carboxylase from Escherichia coli. J. Biochem. 1970;68:227–238. doi: 10.1093/oxfordjournals.jbchem.a129350. [DOI] [PubMed] [Google Scholar]
- 45.Izui K. Effects of high pressure on the stability and activity of allosteric phosphoenolpyruvate carboxylase from Escherichia coli. Biochemistry. 1973;73:505–513. doi: 10.1093/oxfordjournals.jbchem.a130109. [DOI] [PubMed] [Google Scholar]
- 46.Teraoka H., Izui K., Katsuki H. Phosphoenolpyruvate carboxylase of Escherichia coli. Multiple conformational states elicited by allosteric effectors. Biochemistry. 1974;13:5121–5128. doi: 10.1021/bi00722a011. [DOI] [PubMed] [Google Scholar]
- 47.Viappiani C., Bettati S., Bruno S., Ronda L., Abbruzzetti S., Mozzarelli A., Eaton W.A. New insights into allosteric mechanisms from trapping unstable protein conformations in silica gels. Proc. Natl. Acad. Sci. Unit. States Am. 2004;101:14414–14419. doi: 10.1073/pnas.0405987101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Eaton W.A., Henry E.R., Hofrichter J., Bettati S., Viappiani C., Mozzarelli A. Evolution of allosteric models for hemoglobin. IUBMB Life. 2007;59:586–599. doi: 10.1080/15216540701272380. [DOI] [PubMed] [Google Scholar]
- 49.Shibayam N., Sugiyama K., Park S.Y. Structures and oxygen affinities of crystalline human hemoglobin C (β6 Glu->Lys) in the R and R2 quaternary structures. J. Biol. Chem. 2011;286:33661–33668. doi: 10.1074/jbc.M111.266056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Shibayama N. Allosteric transitions in hemoglobin revisited. Biochim. Biophys. Acta Gen. Subj. 2020;1864:129335. doi: 10.1016/j.bbagen.2019.03.021. [DOI] [PubMed] [Google Scholar]
- 51.Bustos-Jaimes I., Ramírez-Costa M., De Anda-Aguilar L., Hinojosa-Ocaña P., Calcagno M.L. Evidence for two different mechanisms triggering the change in quaternary structure of the allosteric enzyme, Glucosamine-6-phosphate deaminase. Biochemistry. 2005;44:1127–1135. doi: 10.1021/bi048514o. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data will be made available on request.








